Research Article

The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department

Volume: 4 Number: 3 November 10, 2022
EN TR

The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department

Abstract

Objective: The aim of this study is to evaluate the performance of CURB-65, Quick Sequential Organ Failure Assessment (qSOFA), and National Early Warning Score 2 (NEWS 2) scores in predicting mortality in COVID-19 patients in emergency department. Method: A total of 502 patients diagnosed with severe COVID-19 in the emergency department of a pandemic hospital were analyzed retrospectively. Demographic, clinical and laboratory data of the patients were obtained from the hospital registry system. The CURB-65, qSOFA, and NEWS2 scores of each patient were calculated separately. These patients were divided into two groups as those who survived and those who died. All parameters and calculated risk scores were statistically compared between these two groups. Results: While 281 out of 502 patients survived, 221 died. When the CURB-65, NEWS2, qSOFA scores were compared between the two patient groups, a significant difference was found (p<0.001 for all ). Compared with CURB-65 and qSOFA, sensitivity of 92.3% and NPV of 90.2% were detected when NEWS2≥8. The NEWS2 score reached the highest mortality predictive power among other scores with an AUC value of 0.86. Conclusion: Because the NEWS2 score is superior to CURB-65 and qSOFA for predicting mortality, it can be used in the triage of severe COVID-19 patients, predicting prognosis and improving outcomes.

Keywords

Supporting Institution

yok

Project Number

yok

Thanks

yok

References

  1. Donnelly CA, Fisher MC, Fraser C, Ghani AC, Riley S, Ferguson NM et al. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect. Dis. 2004;4(11):672-83. doi. org/10.1016/S1473-3099(04)01173-9.
  2. Shi Y, Pandita A, Hardesty A, McCarthy M, Aridi J, Weiss Z.F et all. Validation of pneumonia prognostic scores in a statewide cohort of hospitalised patients with COVID-19. Int J Clin Pract. 2020;e13926. doi: 10.1111/ijcp.13926.
  3. Smith GB, Prytherch DR, Meredith P, Schmidt PE, Featherstone PI. The ability of the National early warning score (news) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation. 2013;84:465–70. doi: 10.1016/j.resuscitation.2012.12.016.
  4. Guo J , Zhou B, Zhu M, Yuan Y , Wang Q, Zhou H et al. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study. Epidemiol Infect. 2020;148:e241. doi: 10.1017/S0950268820002368.
  5. McGinley A, Pearse R. A national early warning score for acutely ill patients. BMJ. 2012;345:e5310. doi: 10.1136/bmj.e5310.
  6. Maitra S, Som A, Bhattacharjee S. Accuracy of quick sequential organ failure assessment (qSOFA) score and systemic inflammatory response syndrome (SIRS) criteria for predicting mortality in hospitalized patients with suspected infection: a metaanalysis of observational studies. Clin Microbiol Infect. 2018;24(11):1123–9. doi: 10.1016/j.cmi.2018.03.032.
  7. Liu S, Yao N, Qiu Y, He C. Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease. Am J Emerg Med. 2020;38(10):2074-2080. doi: 10.1016/.ajem.2020.07.019.
  8. Ministry of Health, Republic of Turkey. Guidance to COVID-19(SARSCov2 infection). https://hsgm.saglik.gov.tr/depo/birimler/gocsagligi/covid19/rehber/COVID-19Rehberi20200414 eng v4 002 14.05.2020.pdf

Details

Primary Language

English

Subjects

Emergency Medicine

Journal Section

Research Article

Publication Date

November 10, 2022

Submission Date

August 13, 2022

Acceptance Date

September 6, 2022

Published in Issue

Year 2022 Volume: 4 Number: 3

APA
Ertekin, B., Yortanlı, M., Özelbaykal, O., Doğru, A., Girişgin, A. S., & Acar, T. (2022). The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phoenix Medical Journal, 4(3), 123-128. https://doi.org/10.38175/phnx.1161754
AMA
1.Ertekin B, Yortanlı M, Özelbaykal O, Doğru A, Girişgin AS, Acar T. The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phnx Med J. 2022;4(3):123-128. doi:10.38175/phnx.1161754
Chicago
Ertekin, Birsen, Mehmet Yortanlı, Ozan Özelbaykal, Ali Doğru, Abdullah Sadık Girişgin, and Tarık Acar. 2022. “The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department”. Phoenix Medical Journal 4 (3): 123-28. https://doi.org/10.38175/phnx.1161754.
EndNote
Ertekin B, Yortanlı M, Özelbaykal O, Doğru A, Girişgin AS, Acar T (November 1, 2022) The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phoenix Medical Journal 4 3 123–128.
IEEE
[1]B. Ertekin, M. Yortanlı, O. Özelbaykal, A. Doğru, A. S. Girişgin, and T. Acar, “The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department”, Phnx Med J., vol. 4, no. 3, pp. 123–128, Nov. 2022, doi: 10.38175/phnx.1161754.
ISNAD
Ertekin, Birsen - Yortanlı, Mehmet - Özelbaykal, Ozan - Doğru, Ali - Girişgin, Abdullah Sadık - Acar, Tarık. “The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department”. Phoenix Medical Journal 4/3 (November 1, 2022): 123-128. https://doi.org/10.38175/phnx.1161754.
JAMA
1.Ertekin B, Yortanlı M, Özelbaykal O, Doğru A, Girişgin AS, Acar T. The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phnx Med J. 2022;4:123–128.
MLA
Ertekin, Birsen, et al. “The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department”. Phoenix Medical Journal, vol. 4, no. 3, Nov. 2022, pp. 123-8, doi:10.38175/phnx.1161754.
Vancouver
1.Birsen Ertekin, Mehmet Yortanlı, Ozan Özelbaykal, Ali Doğru, Abdullah Sadık Girişgin, Tarık Acar. The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phnx Med J. 2022 Nov. 1;4(3):123-8. doi:10.38175/phnx.1161754

Cited By

2392_ccby-295.jpg
Phoenix Medical Journal is licensed under a Creative Commons Attribution 4.0 International License.


2392_boai-189.jpg

Phoenix Medical Journal has signed the Budapest Open Access Declaration.